Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 7791-7795

  Aldemir, Hatice ^a,c   Prod'homme, Virginie ^a,d   Dumaurier, Marie Jeanne ^a   Retiere, Christelle ^b   Poupon, Gwenola ^a   Cazareth, Julie ^a   Bihl, Franck ^a   Braud, Veronique M ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c BAYER AG   (Germany)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 RECEPTOR; CD3 ANTIGEN; CELL SURFACE PROTEIN; GAMMA INTERFERON; LECTIN LIKE TRANSCRIPT 1; LECTIN RECEPTOR; LIGAND; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; RNA; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIGAND BINDING; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

EID: 29144438027     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.7791     Document Type: Article

References (20)

1. Bottino, C., R. Castriconi, L. Moretta, and A. Moretta. 2005. Cellular ligands of activating NK receptors. Trends Immunol. 26: 221-226.
2. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
3. Valiante, N. M., M. Uhrberg, H. G. Shilling, K, Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
4. Kumar, V., and M. E. McNerney. 2005. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5: 363-374.
5. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
6. Lanier, L. L., C. Chang, and J. H. Phillips. 1994. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153: 2417-2428.
7. - T cells. J. Exp. Med. 186: 109-120.
8. Poggi, A., P. Costa, E. Tomasello, and L. Moretta. 1998. IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur. J. Immunol. 28: 1611-1616.
9. Exley, M., S. Porcelli, M. Furman, J. Garcia, and S. Balk. 1998. CD161 (NKR-P1A) costimulation of CD1d-dependenr activation of human T cells expressing invariant Vα24 JαQ T cell receptor α chains. J. Exp. Med. 188: 867-876.
10. Iizuka, K., O. V. Naidenko, B. F. Plougastel, D. H. Fremont, and W. M. Yokoyama. 2003. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4: 801-807.
11. Carlyle, J. R., A. M. Jamieson, S. Gasser, C. S. Clingan, H. Arase, and D. H. Raulet. 2004. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101: 3527-3532.
12. Mathew, P. A., S. S. Chuang, S. V. Vaidya, P. R. Kumaresan, K. S. Boles, and H. T. Pham. 2004. The LLT1 receptor induces IFN-γ production by human natural killer cells. Mol. Immunol. 40: 1157-1163.
13. Eichler, W., P. Ruschpler, M. Wobus, and K. Drossler. 2001. Differentially induced expression of C-type lectins in activated lymphocytes. J. Cell. Biochem. 81: 201-208.
14. Boles, K. S., R. Barten, P. R. Kumaresan, J. Trowsdale, and P. A. Mathew. 1999. Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics 50: 1-7.
15. Allan, D. S., M. Colonna, L. L. Lanier, T. D. Churakova, J. S. Abrams, S. A. Ellis, A. J. McMichael, and V. M. Braud. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189: 1149-1156.
16. Doucey, M. A., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336.
17. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 419: 734-738.
18. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22.
19. Crotta, S., A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Brunetto, F. Bonino, et al. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195: 35-41.
20. Tseng, C. T., and G. R. Klimpel. 2002. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195: 43-49.